Form 8-K - Current report:
SEC Accession No. 0001104659-24-117682
Filing Date
2024-11-13
Accepted
2024-11-13 16:06:22
Documents
14
Period of Report
2024-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2428220d1_8k.htm   iXBRL 8-K 27803
2 EXHIBIT 99.1 tm2428220d1_ex99-1.htm EX-99.1 76949
  Complete submission text file 0001104659-24-117682.txt   286668

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA immu-20241113.xsd EX-101.SCH 3015
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE immu-20241113_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE immu-20241113_pre.xml EX-101.PRE 22359
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2428220d1_8k_htm.xml XML 3688
Mailing Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011
Business Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011 610-321-3700
Immunome Inc. (Filer) CIK: 0001472012 (see all company filings)

EIN.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39580 | Film No.: 241454112
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)